-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICUS PHARMA SUBMITS ORPHAN DRUG DESIGNATION APPLICATION TO U.S. FDA FOR SKINJECT® IN GORLIN SYNDROME

Reuters·04/17/2026 11:30:00

Please log in to view news